 |
|
Infectious diseases experts applaud bill against 'bad bugs'
October 01, 2007Arlington, VA-With extensively drug-resistant tuberculosis, life-threatening drug-resistant respiratory and skin infections, and other "bad bugs" routinely making headlines, infectious diseases physicians are applauding Rep. Jim Matheson (D-UT) and Rep. Michael Ferguson (R-NJ) for introducing H.R. 3697, the Strategies To Address Antimicrobial Resistance (STAAR) Act.
"The STAAR Act has the potential to save thousands of lives," said Martin J. Blaser, MD, past president of the Infectious Diseases Society of America (IDSA). "IDSA strongly supports the STAAR Act and the comprehensive approach that Reps. Matheson and Ferguson are taking to tackle the problem of antimicrobial resistance. Infectious diseases physicians have watched in dismay for years as the antibacterials and other antimicrobials we rely upon to treat our patients have lost their power."
To make matters worse, there are very few new drugs in the pipeline to replace the failing ones, because the pharmaceutical industry now finds developing new antibiotics less appealing than developing drugs for chronic conditions like heart disease. "We are in danger of slipping backward to the era before antibiotics," Dr. Blaser added. "The STAAR Act gets us back in the fight by enhancing federal leadership, encouraging expert input, and by improving our grasp on resistance and ways to control it."
"The issue goes beyond just the pharmaceutical industry," Dr. Blaser said. "We are all in this together-drug companies, physicians, public health experts, and patients. The STAAR Act makes everyone a partner in the solution."
The bill takes a holistic approach to address inappropriate use, a significant problem that diminishes the effectiveness of antibiotics once they are approved.
It vastly improves the nation's capacity to control resistance by establishing a network of experts across the country to conduct regional monitoring of resistant organisms as they occur-a kind of "snapshot" to pick up on problems early.
"It's a different world versus even five years ago," said Neil Fishman, MD, chair of IDSA's Antimicrobial Resistance Work Group. "Multi-drug resistant bugs like Klebsiella and methicillin-resistant Staphylococcus aureus (MRSA) have cropped up and spread practically before anyone has had the chance to examine them under the microscope, much less do anything to stop their spread." The STAAR Act sets up a network to collaborate with the Centers for Disease Control and Prevention on disease surveillance. "The network will be CDC's extra eyes and ears looking out for resistant bugs around the nation and finding ways to prevent their spread," Dr. Fishman added.
In a second major activity of the network, researchers also would work with CDC and the National Institutes of Health to find ways to slow the development of resistance. "We need to determine the best ways to keep approved antibiotics working longer," said Louis Rice, MD, chair of IDSA's Research on Resistance Work Group. "Currently, very little research is focusing on this. The STAAR Act network provides the range of experts we need to study the complex field of drug resistance."
The STAAR Act also creates a board of infectious diseases, public health and veterinary experts to advise the federal government on reducing resistance, and an Office of Antimicrobial Resistance in the Department of Health and Human Services to coordinate, help plan, and guide the government's response to resistance.
IDSA thanks Reps. Matheson and Ferguson for their leadership in introducing this important patient safety and public health bill, and encourages Congress to pass it quickly.
"IDSA has been warning that the 'bad bugs' are getting ahead of us," Dr. Blaser said. "We are glad to see Congress is listening. But we need this legislation to pass soon. It takes years to develop, strengthen, and implement new control strategies. These bad bugs are not waiting."
Infectious Diseases Society of America
"The issue goes beyond just the pharmaceutical industry," Dr. Blaser said. "We are all in this together-drug companies, physicians, public health experts, and patients. The STAAR Act makes everyone a partner in the solution."
The bill takes a holistic approach to address inappropriate use, a significant problem that diminishes the effectiveness of antibiotics once they are approved.
It vastly improves the nation's capacity to control resistance by establishing a network of experts across the country to conduct regional monitoring of resistant organisms as they occur-a kind of "snapshot" to pick up on problems early.
"It's a different world versus even five years ago," said Neil Fishman, MD, chair of IDSA's Antimicrobial Resistance Work Group. "Multi-drug resistant bugs like Klebsiella and methicillin-resistant Staphylococcus aureus (MRSA) have cropped up and spread practically before anyone has had the chance to examine them under the microscope, much less do anything to stop their spread." The STAAR Act sets up a network to collaborate with the Centers for Disease Control and Prevention on disease surveillance. "The network will be CDC's extra eyes and ears looking out for resistant bugs around the nation and finding ways to prevent their spread," Dr. Fishman added.
In a second major activity of the network, researchers also would work with CDC and the National Institutes of Health to find ways to slow the development of resistance. "We need to determine the best ways to keep approved antibiotics working longer," said Louis Rice, MD, chair of IDSA's Research on Resistance Work Group. "Currently, very little research is focusing on this. The STAAR Act network provides the range of experts we need to study the complex field of drug resistance."
The STAAR Act also creates a board of infectious diseases, public health and veterinary experts to advise the federal government on reducing resistance, and an Office of Antimicrobial Resistance in the Department of Health and Human Services to coordinate, help plan, and guide the government's response to resistance.
IDSA thanks Reps. Matheson and Ferguson for their leadership in introducing this important patient safety and public health bill, and encourages Congress to pass it quickly.
"IDSA has been warning that the 'bad bugs' are getting ahead of us," Dr. Blaser said. "We are glad to see Congress is listening. But we need this legislation to pass soon. It takes years to develop, strengthen, and implement new control strategies. These bad bugs are not waiting."
Infectious Diseases Society of America
Infectious Disease Current Events and Infectious Disease News RSSRNA molecules, delivery system improve vaccine responses, effectiveness
A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
'Deadly dozen' reports diseases worsened by climate change
Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies.
Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
Novel platform technologies and key advances in genomics are rapidly driving the development of molecular diagnostics, reports Genetic Engineering and Biotechnology News (GEN).
New way to make malaria medicine also first step in finding new antibiotics
University of Illinois microbiology professor William Metcalf and his collaborators have developed a way to mass-produce an antimalarial compound, potentially making the treatment of malaria less expensive.
Pertussis: Adults can fall severely ill too
Pertussis, also known as whooping cough, is not just a childhood disease.
Hidden infections crucial to understanding, controlling disease outbreaks
Scientists and news organizations typically focus on the number of dead and gravely ill during epidemics, but research at the University of Michigan suggests that less dramatic, mild infections lurking in large numbers of people are the key to understanding cycles of at least one potentially fatal infectious disease: cholera.
Captive breeding introduced infectious disease to Mallorcan amphibians
A potentially deadly fungus that can kill frogs and toads was inadvertently introduced into Mallorca by a captive breeding programme that was reintroducing a rare species of toad into the wild, according to a new study published today in the journal Current Biology.
Experts meet on need for new rules to govern world's fragile polar regions
A new co-ordinated international set of rules to govern commercial and research activities in both of Earth's polar regions is urgently needed to reflect new environmental realities and to temper pressure building on these highly fragile ecosystems, according to several of the experts convening in Iceland for a UN-affiliated conference marking the International Polar Year.
Most vaccine-allergic children can still be safely vaccinated, Hopkins experts say
With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center.
New role for Natural Killers!
Scientists at the University of York have discovered a new role for a population of white blood cells, which may lead to improved treatments for chronic infections and cancer.
More Infectious Disease Current Events and Infectious Disease News Articles
 | Infectious Disease: A Clinical Short Course (In Thirty Days Series) by Frederick S. Southwick Gain a full understanding of clinical infectious diseases in just thirty days No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens-simulating how common pathogens and disorders would be encountered in rounds or in... |
 | Infectious Diseases of the Dog and Cat , Revised Reprint (Infectious Diseases of the Dog and Cat) by Craig E. Greene Featuring full-color illustrations and hundreds of tables with diagnostic and therapeutic guidelines, this authoritative resource explores the diagnosis and treatment of canine and feline infectious diseases caused by viruses, rickettsiae, chlamydiae, mycoplasmas, bacteria, fungi, algae, protozoa, and unknown agents. Discussion of each disease includes diagnostic testing, indications and methods... |
 | Infectious Disease Epidemiology: Theory And Practice by Kenrad E., M.D. Nelson, Carolyn F. Masters, Ph.D. Williams This comprehensive resource applies the fundamentals of epidemiology to the study of infectious diseases (ID). In the first section, readers will learn about basic epidemiologic methods for the study of ID plus be introduced to newer techniques like geographical information systems, mathematical modeling, and genetic laboratory tools. In the second section, the book covers major infectious... |
 | Evolution of Infectious Disease by Paul W. Ewald Findings from the field of evolutionary biology are yielding dramatic insights for health scientists, especially those involved in the fight against infectious diseases. This book is the first in-depth presentation of these insights. In detailing why the pathogens that cause malaria, smallpox, tuberculosis, and AIDS have their special kinds of deadliness, the book shows how efforts to control... |
 | Modeling Infectious Diseases in Humans and Animals by Matt J. Keeling, Pejman Rohani For epidemiologists, evolutionary biologists, and health-care professionals, real-time and predictive modeling of infectious disease is of growing importance. This book provides a timely and comprehensive introduction to the modeling of infectious diseases in humans and animals, focusing on recent developments as well as more traditional approaches. Matt Keeling and Pejman Rohani move from... |
 | Clinical Infectious Disease This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes... |
 | Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS) Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic... |
 | Essential Infectious Disease Topics for Primary Care (Current Clinical Practice) Although infectious disease mortality is decreasing, the disease burden remains substantial as many new infections have been identified and some well-established infectious diseases have reemerged. This book provides an easy-to-use, practical, yet comprehensive resource for family practitioners to use in the daily struggle against infectious diseases. It discusses vaccines and preventive measures... |
 | Current Diagnosis & Treatment in Infectious Diseases by Walter R. Wilson, Merle A. Sande Internationally renowned infectious disease experts offer guidance in recognizing, diagnosing, treating, and preventing one of the leading causes of death worldwide. Clinically focused and comprehensive, the book covers the essentials of diagnosis and syndromes in children and adults. Examines antimicrobial resistance and balances expert, practice-oriented coverage with just the right amount of... |
 | Immunity: The Immune Response to Infectious and Inflammatory Disease (Primers in Biology) by Anthony DeFranco, Richard Locksley, Miranda Robertson An understanding of the immune system is central to the understanding of how the body interacts with its surroundings, and how it both protects itself and responds to infectious disease. But what processes underpin the body's response to infection? How does our immune system remember its previous encounters? And what happens when the tight regulation of the immune system fails? Immunity:... |
| © 2008 BrightSurf.com |